Jean-Marc Lacorte Selected Research

Triglycerides (Triacylglycerol)

1/2020	Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response.
1/2020	Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study.
2/2016	Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport.
1/2015	Ghrelin, adipokines, metabolic factors in relation with weight status in school-children and results of a 1-year lifestyle intervention program.
6/2012	The transcription factor HNF-4α: a key factor of the intestinal uptake of fatty acids in mouse.
5/2010	Postprandial metabolic and hormonal responses of obese dyslipidemic subjects with metabolic syndrome to test meals, rich in carbohydrate, fat or protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Marc Lacorte Research Topics

Disease

13	Obesity 12/2021 - 06/2007
11	Insulin Resistance 01/2020 - 12/2003
8	Neoplasms (Cancer) 01/2023 - 04/2002
6	Weight Loss (Weight Reduction) 01/2022 - 01/2005
4	COVID-19 01/2022 - 01/2021
4	Morbid Obesity 01/2021 - 05/2006
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2019
3	Hypertriglyceridemia 01/2020 - 05/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 05/2010
3	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 01/2003
2	Metabolic Diseases (Metabolic Disease) 04/2024 - 04/2009
2	Short Bowel Syndrome 09/2023 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2012
2	Inflammation (Inflammations) 09/2018 - 01/2011
2	Non-alcoholic Fatty Liver Disease 10/2017 - 07/2008
2	Hyperphagia (Overeating) 12/2016 - 02/2013
2	Breast Neoplasms (Breast Cancer) 03/2016 - 11/2014
2	Hyperlipidemias (Hyperlipidemia) 02/2016 - 07/2015
2	Overweight 01/2015 - 08/2005
2	Dyslipidemias (Dyslipidemia) 05/2010 - 08/2005
1	Pericardial Effusion 01/2023
1	Chylous Ascites 01/2023
1	Chylothorax 01/2023
1	Erdheim-Chester Disease 01/2023
1	Anaplastic Thyroid Carcinoma 09/2022
1	Reinfection 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Glioma (Gliomas) 01/2021
1	Alcoholic Fatty Liver 01/2020
1	Abdominal obesity metabolic syndrome 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 02/2019
1	Liver Abscess 02/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Peripheral Arterial Occlusive Disease 1 01/2019
1	Vascular Calcification 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Body Weight (Weight, Body) 10/2017
1	Fatigue 01/2017

Drug/Important Bio-Agent (IBA)

11	LeptinIBA 01/2021 - 01/2005
9	AdiponectinIBA 01/2020 - 12/2003
6	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2010
6	Insulin (Novolin)FDA Link 01/2015 - 08/2005
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2011
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2005
4	Hormones (Hormone)IBA 01/2020 - 09/2013
3	LipidsIBA 12/2022 - 01/2010
3	Leptin ReceptorsIBA 01/2019 - 02/2013
3	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 10/2017 - 05/2006
3	AdipokinesIBA 12/2016 - 08/2005
3	GhrelinIBA 12/2016 - 01/2015
3	Lipoproteins (Lipoprotein)IBA 06/2012 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 05/2010
2	CytokinesIBA 01/2021 - 01/2010
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021 - 10/2017
2	AntibodiesIBA 01/2021 - 10/2016
2	CholesterolIBA 01/2020 - 02/2016
2	CarbohydratesIBA 02/2019 - 05/2010
2	C-Reactive ProteinIBA 09/2018 - 01/2011
2	Peptides (Polypeptides)IBA 01/2018 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 05/2010 - 01/2010
1	Apolipoprotein B-48IBA 09/2023
1	ChylomicronsIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2022
1	dabrafenibIBA 09/2022
1	trametinibIBA 09/2022
1	AldosteroneIBA 01/2022
1	ReninIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	VaccinesIBA 01/2021
1	MelanocortinsIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	LigandsIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 02/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2019
1	AntigensIBA 02/2019
1	Troponin T (Troponin T1)IBA 09/2018
1	GlicentinIBA 01/2018
1	Proglucagon (Glucagon Precursors)IBA 01/2018
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 12/2017
1	Protons (Proton)IBA 10/2017
1	setmelanotideIBA 10/2017
1	hydroxide ionIBA 12/2016
1	Vitamin D FDA LinkGeneric 12/2016
1	25-hydroxyvitamin DIBA 12/2016

Therapy/Procedure

4	Therapeutics 01/2023 - 07/2008
3	Drug Therapy (Chemotherapy) 01/2019 - 11/2014
3	Bariatric Surgery 05/2016 - 02/2013
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 01/2018
1	Parenteral Nutrition 09/2023
1	Critical Care (Surgical Intensive Care) 12/2021
1	Liver Transplantation 02/2019
1	Endovascular Procedures 01/2019
1	Immunotherapy 12/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2017